Skip to main content
Fig. 2 | BMC Rheumatology

Fig. 2

From: Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany

Fig. 2

Total healthcare costs (Euro) per patient-year by follow-up year

(A) All SLE patients and the comparator cohorta and (B) patients with SLE with organ damage and without organ damage

aPatients with a confirmed SLE diagnosis during the inclusion period were propensity score–matched (1:3) to a comparator cohort without SLE by age, sex, categories of comorbid conditions per CCI, and CCI score

CCI: Charlson comorbidity index; PY: patient-year; SLE: systemic lupus erythematosus

Back to article page